Gene: JRKL
Official Full Name: JRK likeprovided by HGNC
Gene Summary: The function of this gene has not yet been defined, however, the encoded protein shares similarity with the human (41% identical) and mouse (34% identical) jerky gene products. This protein may act as a nuclear regulatory protein. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, May 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33951 | JRKL Knockout cell line (HeLa) | Human | JRKL | 1:3~1:6 | Negative | Online Inquiry |
KO33952 | JRKL Knockout cell line (HCT 116) | Human | JRKL | 1:2~1:4 | Negative | Online Inquiry |
KO33953 | JRKL Knockout cell line (HEK293) | Human | JRKL | 1:3~1:6 | Negative | Online Inquiry |
KO33954 | JRKL Knockout cell line (A549) | Human | JRKL | 1:3~1:4 | Negative | Online Inquiry |
JRKL Gene Knockout Cell Lines are genetically modified cell lines designed specifically for gene function studies and therapeutic development. These cell lines have undergone targeted genome editing, which effectively disables the expression of specific genes, enabling researchers to investigate the phenotypic consequences of gene loss. This innovative product harnesses technologies such as CRISPR/Cas9 to create precise and reproducible knockouts, facilitating robust experimental designs in both basic and applied biological research.
The key functions of JRKL Gene Knockout Cell Lines revolve around their ability to mimic gene loss-of-function scenarios observed in various diseases. By using these cell lines, researchers can conduct experiments to elucidate gene functions, understand disease mechanisms, and assess the potential efficacy of therapeutic interventions. This model system provides essential insights into cellular processes, signaling pathways, and protein interactions that are pivotal for drug discovery and validation.
The scientific significance of these knockout cell lines is profound, with applications ranging from basic research investigations into gene roles in cellular physiology to translational studies aimed at developing gene-targeted therapies. Their ability to reproduce certain disease states enhances their value in preclinical testing and enables the exploration of gene-targeted interventions with increased precision.
Compared to alternative products, such as traditional knockout models or non-targeted cell lines, JRKL Gene Knockout Cell Lines offer enhanced specificity, time savings, and cost-effectiveness. The use of CRISPR/Cas9 technology eliminates many traditional challenges associated with gene knockout methods, such as off-target effects and lengthy generation times.
For researchers and clinicians, JRKL Gene Knockout Cell Lines represent a powerful tool for advancing scientific knowledge and developing therapeutic solutions. Their reliability and innovative design make them indispensable in any genomic study, proving valuable in unraveling complex gene interactions and disease mechanisms. With a commitment to quality and scientific integrity, our company provides expertly engineered biological products to enhance research and clinical outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.